N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2,4-difluoro-L-Phenylalanine is a non-natural, fluorinated amino acid derivative. Its chemical structure features an L-phenylalanine backbone with fluorine atoms at the 2- and 4-positions of the aromatic ring, and the alpha-amino group is protected by the 9-fluorenylmethoxycarbonyl (Fmoc) group. This specific protection makes it a crucial building block in solid-phase peptide synthesis (SPPS). This compound is primarily used as a specialized amino acid building block for the synthesis of peptides and peptidomimetics. The incorporation of the 2,4-difluorophenylalanine residue can significantly alter the biological activity, metabolic stability, and physicochemical properties (such as lipophilicity and conformational preference) of the resulting peptides. It is particularly valuable in medicinal chemistry research for developing peptide-based drugs, enzyme inhibitors, and probes where fluorination is used to modulate binding affinity or improve pharmacokinetic profiles. As an Fmoc-protected derivative, it is directly compatible with standard Fmoc-SPPS protocols, allowing for automated peptide assembly. Its main application lies in the research and development of novel therapeutic peptides, making it a key intermediate in pharmaceutical discovery.